Trademark: 90160114
Word
ALYGLO
Status
Pending
Status Code
733
Status Date
Wednesday, February 14, 2024
Serial Number
90160114
Mark Type
4000
Filing Date
Friday, September 4, 2020
Published for Opposition
Tuesday, April 20, 2021

Trademark Owner History
Green Cross Corporation - Owner At Publication

Classifications
5 Blood plasma derivatives for medical purposes, namely, immune globulins including Rh immune globulin; Immunoglobulin preparations, namely, pharmaceutical immunoglobulin preparations for diagnosis of primary humoral immunodeficiency, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich syndrome, severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP), for preventing primary humoral immunodeficiency, Kawasaki disease, Guillain-Barre syndrome, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich syndrome and severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, cardiovascular disease, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP), and for treatment of primary humoral immunodeficiency, Kawasaki disease, Guillain-Barre syndrome, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich Syndrome and severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, cardiovascular disease, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP); all the foregoing for patient treatment by injection or in liquid form by health professional

Trademark Events
Feb 15, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 14, 2024
Sou Extension 4 Granted
Feb 14, 2024
Sou Extension 4 Filed
Feb 14, 2024
Sou Teas Extension Received
Aug 30, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 28, 2023
Sou Extension 3 Granted
Aug 28, 2023
Sou Extension 3 Filed
Aug 28, 2023
Sou Teas Extension Received
Feb 24, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 22, 2023
Sou Extension 2 Granted
Feb 22, 2023
Sou Extension 2 Filed
Feb 22, 2023
Sou Teas Extension Received
Aug 4, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 2, 2022
Sou Extension 1 Granted
Aug 2, 2022
Sou Extension 1 Filed
Aug 2, 2022
Sou Teas Extension Received
Mar 24, 2022
Teas Change Of Correspondence Received
Mar 24, 2022
Teas Change Of Domestic Representatives Address
Mar 24, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 24, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 1, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 7, 2022
Changes/Corrections After Pub Approval Entered
Feb 2, 2022
Assigned To Petition Staff
Jan 26, 2022
Teas Post Publication Amendment Received
Jan 20, 2022
Ttab Release Case To Trademarks
Jan 20, 2022
Opposition Terminated No. 999999
Jan 20, 2022
Opposition Dismissed No. 999999
Oct 18, 2021
Opposition Instituted No. 999999
May 6, 2021
Extension Of Time To Oppose Received
Apr 20, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 20, 2021
Published For Opposition
Mar 31, 2021
Notification Of Notice Of Publication E-Mailed
Mar 12, 2021
Approved For Pub - Principal Register
Mar 11, 2021
Teas/Email Correspondence Entered
Mar 10, 2021
Correspondence Received In Law Office
Mar 10, 2021
Teas Response To Office Action Received
Jan 13, 2021
Notification Of Priority Action E-Mailed
Jan 13, 2021
Priority Action E-Mailed
Jan 13, 2021
Priority Action Written
Jan 12, 2021
Assigned To Examiner
Oct 9, 2020
New Application Office Supplied Data Entered
Sep 8, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24